The AI + Biopharma Luncheon at SynBioBeta 2026 brings together innovators working at the intersection of artificial intelligence and life sciences. This gathering offers a chance for founders, researchers, investors, and industry leaders to connect over lunch while exploring how AI is accelerating drug discovery, transforming R&D workflows, and reshaping the future of biopharma.
The luncheon will also feature a panel discussion with Vivek Ardash, CEO of Mithrl, and Eric Kauderer-Abrams, Life Sciences at Anthropic, offering perspectives on how frontier AI models, scientific reasoning systems, and new computational tools are beginning to change the way biopharma teams generate insights, design experiments, and move from discovery to development.
